1. Introduction {#sec1}
===============

Neuromyelitis optica (NMO) is a demyelinating disorder with manifestations similar to those of multiple sclerosis (MS). The two conditions are so similar that NMO has long been considered a variant of MS rather than a separate disease ([@ref22]). Anti-aquaporin-4 (AQP4) is an antibody recently discovered in serum samples that can be used to distinguish MS from NMO ([@ref22]). However, differentiating NMO from MS may still pose difficult challenges for clinical decision-making ([@ref17]; [@ref48]) because an ideal anti-AQP4 assay requires the newer techniques (e.g., cell-based) and samples from a patient over time rather than a single serum sample drawn during an NMO clinical attack ([@ref17]). Thus, a subset of patients remains seronegative. Consequently, recent efforts have focused on better characterizing the differential features of NMO ([@ref34]).

These efforts parallel the advancement of magnetic resonance imaging (MRI) and computational tools, which are drawing increasing interest among other candidate biomarkers. Potential imaging biomarkers might include lesion morphology in ultra-high field MRI ([@ref36]), gray matter damage ([@ref6]; [@ref31]), normal-appearing white matter ([@ref26]), and resting-state functional MRI (fMRI) ([@ref23]). Moreover, another distinguishing feature could be cognitive functioning, which is affected in both MS and NMO by various underlying pathomechanisms ([@ref6]; [@ref33]). However, previous studies have focused on a limited set of measures, and a unified model that combines imaging, cognitive and clinical data is still lacking. Similar automatic diagnostic models have been successfully used to evaluate Alzheimer\'s disease and traumatic brain injury ([@ref20]; [@ref24]), and it would be interesting to apply them to patients with two similar demyelinating disorders.

Although information from multiple sources has a great promise for application in clinical settings, their interpretation is not easy. A new method that has addressed this problem is multiple-kernel learning ([@ref39]; [@ref50]). Kernels provide functions that transform data into another mathematical space in which separation of subjects may be easier, and when they are combined, weights associated with each kernel could also be learned. This approach provides an intuitive interpretation for the importance of each source of information ([@ref39]). So far previous works in MS have used single kernel methods ([@ref5]; [@ref15]; [@ref47]) on a limited number of MRI modalities.

Here, we aimed to develop a unifying model that incorporates clinical, imaging and cognitive measures to predict the diagnosis of each subject. First, we selected *a priori* measures that are potentially affected during MS or NMO ([Table 1](#t0005){ref-type="table"}). Next, we used a multi-kernel classifier to investigate the importance of each modality and calculated the accuracy of discrimination between MS and NMO with cross-validation. We hypothesized that multi-modal classification would achieve high accuracy in differentiating MS from NMO. To further validate our approach, we implemented the same procedure to differentiate patients with each of these disorders from healthy controls, and in a multi-class classification problem, we differentiated between all three groups of patients with MS, NMO and healthy controls.

2. Materials and methods {#sec2}
========================

2.1. Settings and participants {#sec2.1}
------------------------------

A total of 35 healthy controls, 30 patients with NMO, and 25 patients with relapsing--remitting MS were included in this study ([@ref46]). All patients were recruited at Sina MS Research Center, Sina Hospital, Tehran, Iran between 2009 and 2012. We included patients based on previously acknowledged criteria: MS diagnosis according to the McDonald criteria, which were revised in 2005 ([@ref27]), and NMO diagnosis according to Wingerchuk\'s criteria, which were revised in 2006 ([@ref48]). Exclusion criteria included (1) clinical attacks within 6 weeks of study initiation, (2) IV methyl-prednisolone administration during the prior 6 weeks, (3) pregnancy and (4) neurological or psychiatric disorders other than MS or NMO. Among the 30 patients with NMO, 56% (17/30) were positive for anti-aquaporin-4 using indirect immunofluorescence (reference laboratory: [[http://www.bioscientia.de]{.ul}](http://www.bioscientia.de){#interref1}, Ingelheim, Germany), whereas all patients with MS were negative. Healthy controls, patients with MS and patients with NMO were matched according to age, gender, and educational level. All patients underwent a full neurological assessment and were scored on the Expanded Disability Status Scale (EDSS) ([@ref48]) in addition to the 9-hole peg and 25-foot walk tests ([@ref7]). All subjects signed written consent forms in accordance with the Declaration of Helsinki ([@ref49]). The study protocol was approved by the Ethical Committee at Tehran University of Medical Sciences.

2.2. Cognitive assessment {#sec2.2}
-------------------------

A neuropsychologist assessed all subjects according to our standard protocol ([@ref10]). Based on our previous study, we chose the two most sensitive cognitive tests identified in Iranian MS patients, namely the Symbol Digit Modality Test (SDMT) and the California Verbal Learning Test version 2 (CVLT-II) ([@ref10]). Test administration and scoring are described in [Table 1](#t0005){ref-type="table"}. All subjects underwent cognitive assessment 1 week prior to MRI scanning. None of the patients experienced any clinical relapses during this period.

2.3. MRI protocol {#sec2.3}
-----------------

Scanning was performed using a 3 T Siemens Trio scanner (Erlangen, Germany) with a standard 12-channel head coil. A unique protocol was used for all participants that included axial FLAIR (TR/TE = 9000/93 ms, slice thickness = 3 mm, FOV = 220 mm, TI = 2500 ms), axial T2 (TR/TE = 4000/91 ms, slice thickness = 3 mm, 42 slices), 3D magnetization-prepared rapid acquisition with gradient echo (3D-MPRAGE, TR/TE = 2530/3.44 ms, 1 mm isotropic voxel size, TI = 1100 ms, FOV = 256 mm), and axial DTI (single-shot diffusion-weighted EPI, *b* = 1000 s, 30 directions with 2 averages, TR/TE = 12,000/90 ms, 1.7 × 1.7 × 2 mm voxel size, 68 slices with no gap, 4 diffusion runs without diffusion weighting (*b* = 0/s)). Functional MRI images were obtained during a resting state for 7.5 min using a T2\*-weighted EPI sequence with whole-brain coverage (TR/TE = 2200/30 ms, 40 interleaved slices with thickness = 3 mm and no gap, voxel size isotropic 3 mm with 200 volumes). During fMRI acquisition, subjects were asked to keep their eyes closed and to avoid thinking of anything in particular.

2.4. Image analysis {#sec2.4}
-------------------

We used a hypothesis-based approach to select certain measures that are known to be affected by MS or NMO, which are shown in [Table 1](#t0005){ref-type="table"}. Accordingly, we calculated the following measures from the MRI data: 1) average cortical thickness in regions defined according to the Desikan--Killiany atlas ([@ref9]) (T1-weighted images), 2) average of deep gray matter nuclei volumes (T1-weighted images), 3) T1 hypointense lesion load 4) T2/FLAIR lesion volume, 5) corticospinal tract fractional anisotropy (FA) (DTI), 6) optic radiation FA (DTI), 7) corpus callosum FA (DTI), 8) sensorimotor network connectivity (fMRI), 9) default mode network connectivity (fMRI), 10) visual network connectivity (fMRI), and 11) cross-sectional upper cervical cord area (T1). Evidence supporting the selection of each measure is provided in [Table 1](#t0005){ref-type="table"}.

### 2.4.1. Lesion segmentation: visible white matter lesions {#sec2.4.1}

We segmented hyperintense lesions on FLAIR sequences with the lesion segmentation toolbox in SPM8 ([@ref35]). Lesion binary maps were then manually verified using T2-weighted images and edited. We then used the final white matter (WM) binary lesion maps to calculate the lesion load and fill hypointense lesions in T1 -weighted images with the mean intensity of normal-appearing white matter ([@ref29]). Separately, we manually segmented T1 hypointense lesions on the unprocessed T1-weighted images using Jim software and calculated the lesion volume for each subject.

### 2.4.2. Cortical thickness analysis {#sec2.4.2}

We analyzed the cortical thickness and subcortical volumes of lesion-filled 3D-MPRAGE images using FreeSurfer 5.10 as described by Fischl et al. ([@ref8]). The final results were manually confirmed for each subject, then the pipeline was performed again in 22 subjects to achieve satisfactory segmentation. The average thickness of all cortical parcellations and the average volumes of the thalamus, caudate nucleus, putamen and globus pallidus were calculated for each subject.

### 2.4.3. DTI analysis: normal-appearing WM {#sec2.4.3}

We used FSL 4.1.9 to post-process diffusion-weighted volumes. Diffusion-weighted images were registered to the image without diffusion weighting (b0) using affine transformations to minimize distortion due to motion and eddy currents and then brain-extracted using the Brain Extraction Tool (BET) ([@ref37]). Fractional anisotropy (FA) images were generated using FMRIB\'s diffusion toolbox (FDT). We non-linearly aligned all FA images with the FMRIB58 template as the common registration target. The corpus callosum, bilateral optic radiations, and corticospinal tracts were masked in the common template using the Jülich probabilistic histological atlas in FSL ([@ref43]), and these binary masks were inverse-warped to each subject\'s native space ([Fig. 1](#f0005){ref-type="fig"}). Next, we subtracted the visible WM lesion masks acquired from the lesion segmentation step above, from the ROI defined by the atlas. Accordingly, only normal-appearing WM voxels remained in the pathway of each defined tract. Finally, the FA average of each mask was extracted for all subjects.

### 2.4.4. Resting-state fMRI analysis {#sec2.4.4}

We employed a group independent component analysis and a dual regression approach to study functional network connectivity in MS and NMO patients and in healthy subjects using FSL ([@ref3]; Filippini et al., 2009). The pre-statistics processing of fMRI images consisted of removing the first 5 volumes from each time-series, brain extraction, motion correction, slice timing correction for interleaved acquisition, high-pass filtering with a frequency cut-off of 100 s, spatial smoothing using a Gaussian kernel of full-width at half-maximum (5 mm), and transformation to an MNI-152 standard template. To identify resting-state networks, we performed independent component analysis on scans acquired from healthy controls with automatic dimensionality estimation, which revealed 53 spatio-temporal components ([@ref4]). Of these, we selected 3 components (the default mode, sensorimotor and visual networks, see below for maxima coordinates) based on cross-correlation with a previous meta-analytical template of resting-state networks (available online at [[http://www.fmrib.ox.ac.uk/analysis/brainmap+rsns/]{.ul}](http://www.fmrib.ox.ac.uk/analysis/brainmap+rsns/){#interref2}) and visual neuroanatomical correspondence ([@ref38]) ([Fig. 1A, B and C](#f0005){ref-type="fig"}).

Next, we used a dual regression approach for all subjects (both patients and controls) to identify spatial maps and corresponding timecourses for each component. At the first stage, group-level spatial maps were used as a set of spatial regressors to determine the temporal dynamics of the components at the subject level. Next, these timecourses were variance-normalized to allow comparison of the shape and amplitude of resting-state networks. At the second stage, the timecourses were used as temporal regressors to determine spatial maps at the subject level. Finally, a region-of-interest analysis was performed on the resulting maps to extract the functional connectivity from each subject. For this step, we used reference network coordinates from the reference maps. The peak of the independent component analysis calculated on healthy subjects for the default mode (*X* = −0.2, *Y* = −55.4, *Z* = 14.5, in mm, MNI space), sensorimotor (right: *X* = 33.4, *Y* = −16.3, *Z* = 53.7; left: *X* = −29.6, *Y* = −17.8, *Z* = 57) and visual networks (*X* = 0.9, Y = −93.8, *Z* = --4) was used to define the center of a 10-mm spherical mask in MNI152 space. The mean functional connectivity values (*z*-scores) with respective resting-state networks were calculated for each subject.

### 2.4.5. Upper cord cross-sectional area calculation {#sec2.4.5}

We used a semi-automatic method in the Jim software to calculate the average cord cross-sectional area from the foramen-magnum to C2 on 3D-MPRAGE scans as described elsewhere ([@ref16]).

2.5. Statistical analysis {#sec2.5}
-------------------------

### 2.5.1. Descriptive statistics {#sec2.5.1}

The mean age, disease duration, and years of education along with the median and range of the EDSS score were calculated. We also calculated the correlation coefficient among each pair of measures.

### 2.5.2. Predictive modeling: training and cross-validation {#sec2.5.2}

We used the Caret package inside R version 3.1.1 ([@ref21]) and the Shogun toolbox version 3.2.0 inside C++. We included all 18 variables ([Table 1](#t0005){ref-type="table"}) in a support vector machine (SVM). The SVM is a standard model to investigate variables with binary (e.g., MS and NMO) or multi-class outcomes (e.g., MS, HCs and NMO) ([@ref14]; [@ref19]). The SVM is a kernel-based method, has been extensively validated as a diagnostic model for neuroimaging ([@ref20]; [@ref40]), and can handle heterogenous data from multiple sources with a combination of kernels ([@ref39]). Similar to [@ref50] we use one kernel for each modality, combine them, learn each kernel\'s weight during training, and finally classify patients in the test set. Modality is referred to each source of information, that is one for clinical scores, one for cognitive scores, and 5 for imaging ([Fig. 2](#f0010){ref-type="fig"}).

We distinguished between groups with two approaches: 1) binary classification with 3 different models: NMO vs MS, healthy control (HC) vs MS, and HC vs NMO, and 2) multi-class classification (one-vs-rest method): we distinguished between MS and both patients with NMO or HCs using multiple one-vs-rest models ([@ref30]). When comparing patients to HCs, we excluded measures that were unavailable for healthy volunteers (EDSS and low-contrast test score). Ten-fold cross validation was used to partition data into 10 chunks, each of which were used once for testing and the remaining 9 were used to train the classifiers and to calculate the kernel weights. We report the average accuracy of the classifier over 10 folds. For simplicity and ease of interpretation, we used linear kernels in all SVMs in this study, except for multi-class classification where we used polynomial and Gaussian kernels.

3. Results {#sec3}
==========

3.1. Clinical and demographic characteristics {#sec3.1}
---------------------------------------------

The mean age of patients with NMO was 33.58 years, with a mean disease duration of 6.07 years and a median EDSS score of 3 (detailed demographic measures are shown in [Table 2](#t0010){ref-type="table"}). The disease-modifying drugs used by patients with NMO consisted of the following: azathioprine in 18 patients, mycophenolate mofetil in 5 patients, mitoxantrone in 1 patient, cyclophosphamide in 1 patient, methotrexate in 1 patient and oral prednisolone in 1 patient; the remaining patients did not receive any medications. Patients with MS received the following disease-modifying drugs: 17 patients received β-interferon, 2 received azathioprine and 1 received mitoxantrone; the remaining patients did not receive medication.

3.2. Descriptive statistics {#sec3.2}
---------------------------

[Fig. 3](#f0015){ref-type="fig"} shows the median and 75th percentile of the imaging (A) and clinical (B) predictors in boxplots. [Fig. 4](#f0020){ref-type="fig"} shows the correlation maps among all variables.

3.3. Importance of each modality and prediction of diagnosis {#sec3.3}
------------------------------------------------------------

### 3.3.1. MS and NMO {#sec3.3.1}

Mean accuracy of this model was 88 % with a standard deviation (SD) of 11. The important modalities ([Fig. 2](#f0010){ref-type="fig"} and [Table 3](#t0015){ref-type="table"}) according to their kernel weights were: 1) visible WM lesion load, 2) DTI, 3) fMRI, 4) cognitive scores, 5) gray matter measures, 6) spinal cord area, and 7) clinical scores. Among patients with seronegative NMO, 83% and patients with seropositive NMO, 88% were correctly classified over all test sets (*p* \> 0.05 for equality of proportions). When only using the most important modality (visible WM lesion load) the average accuracy was 74%.

### 3.3.2. MS and HC {#sec3.3.2}

The mean accuracy was 91% with an SD of 8. Important modalities were: 1) visible WM lesion load, 2) DTI, 3) clinical scores, 4) fMRI, 5) cognitive scores, 6) gray matter measures, and 7) spinal cord area. When only using the most important modality, the average accuracy was 76%.

### 3.3.3. NMO and HC {#sec3.3.3}

The mean accuracy was 78% with an SD of 12. Important modalities were: 1) clinical scores, 2) cognitive scores, 3) fMRI, 4) DTI, 5) gray matter measures, 6) spinal cord area, and 7) visible WM lesion load. When using only the most important modality (clinical scores) the average accuracy was 71%.

### 3.3.4. Multi-class classification: classification of MS, NMO and HCs in a single model {#sec3.3.4}

The mean accuracy (±SD) was 84% with an SD of 8. Important modalities for multi-label classification were: 1) visible WM lesions 2) fMRI 3) cognitive scores 4) DTI. Other modalities received 0 weights in the combined kernel. When using the most important modality (visible WM lesion load) the average accuracy was 74%.

4. Discussion {#sec4}
=============

The main purpose of this study was to integrate clinical, imaging and cognitive measures to automatically distinguish patients with MS from those with NMO.

We combined kernels to unify heterogenous data from multiple sources, and to distinguish MS from NMO. We further extended our model to multi-class algorithms, where we classified MS, NMO and HCs in a single model with a high accuracy (84%). When looking at each pair of groups, the accuracy of the model was 88% to distinguish MS and NMO patients, 91% between HCs and patients with MS, and 78% between HCs and patients with NMO. The most important modalities, according to their kernel weights, revealed that when distinguishing the NMO and MS groups differential changes were mostly found in WM measures (visible WM lesion load and normal appearing white matter integrity), followed by the resting-state fMRI connectivity and cognitive functioning. To the best of our knowledge this is the first study to classify two similar demyelinating disorders with multi-modal data fusion.

There is an increasing interest in the neuroimaging community to use computational and diagnostic models. They have been previously used to evaluate Alzheimer\'s disease, traumatic brain injury, and stroke, showing performance that is comparable to that of human experts ([@ref20]; [@ref24]; [@ref42]; [@ref50]). Our study gives preliminary evidence for the utility of computational tools in differentiating MS and NMO, the results of which could have important implications for developing future clinical decision-making algorithms.

Multivariate data-fusion methods can identify complex patterns of neuroanatomical changes ([@ref41]). When distinguishing between the NMO and MS groups, the visible WM lesion load (T1 and T2 lesion load) and normal-appearing WM integrity (DTI) were the most important features, showing a consistent damage in the MS group among different measures. The next important modality was resting-state functional connectivity, which consisted of connectivities of default-mode, sensorimotor and visual networks. When looking at individual measures in [Fig. 3A](#f0015){ref-type="fig"}, the sensorimotor and default-mode networks show more variability between groups than the visual network. The visual network is responsible for a "basic" function that is not expected to differ between groups, which increases our confidence that the differences between other networks are meaningful, as was shown in a previous study ([@ref32]). We observed a consistent damage in WM and GM in patients with MS in comparison with the NMO patients and HCs. In patients with NMO, this coincided with an increased sensorimotor network connectivity and may indicate that more subtle motor system damage in the brains of patients with NMO is associated with an increased connectivity in the sensorimotor network, possibly due to compensatory effects ([Fig. 3A](#f0015){ref-type="fig"}) ([@ref25]). Interestingly, when comparing DMN connectivity in each group of patients with that of healthy controls, a subtle decrease in DMN connectivity in NMO but not MS patients was associated with sustained cognitive functioning ([Fig. 3A and Fig. 4](#f0015 f0020){ref-type="fig"}). This finding is consistent with previous studies, indicating the role of DMN suppression in supporting externally oriented cognitive functioning ([@ref1]). These findings show that multivariate pattern classification using an SVM can integrate complex brain changes to support clinical diagnoses.

Multi-class classification better reflects a dilemma in routine clinical practice, when more than one differential diagnosis are considered ([@ref19]). Our model reached excellent accuracy (84%) to distinguish between all three groups. Visible WM lesions, fMRI, cognitive scores and DTI received high weights while other modalities received 0 weights. A classification based on only visible white matter lesions showed an accuracy of 74%, which highlights the importance of more advanced modalities in difficult classification problems. Future studies should include other common differential diagnoses of MS, such as CNS vasculitis in a multi-class classification problem.

It is also important to acknowledge several limitations of our study. First, this is a single-center classification study that can only provide preliminary results and does not ensure between-cohort generalization. Future studies will incorporate our data with data from other centers to evaluate the robustness of the model. Second, we found similar performance in distinguishing seronegative and seropositive NMO patients (83% vs 88%) from patients with MS, however, an ideal situation would be to recruit enough patients to train a model on seropositive patients with NMO and then test new patients with seronegative NMO, the results of which could support the clinical diagnosis when the serum assay remains negative. The third limitation is that our gold standard for classification remains a diagnosis made by an expert neurologist based on the acknowledged criteria, and we could not exclude the possibility of mislabeling due to imperfect diagnostic criteria for MS and NMO. Without solving this issue, perfect classification is impossible. This limitation might be overcome by longer follow-up of patients and employing frequent diagnostic procedures (e.g., multiple serum samples for anti-aquaporin-4 over time).

In conclusion, our workflow produces accurate models for differentiating patients with NMO from those with MS and from healthy volunteers. The combination of imaging with clinical and cognitive measures provides further improvement of the accuracy and could disentangle complex changes across several modalities. This work provides proof-of-concept evidence for the premise of computational models that aid in the objective differential diagnosis of MS and NMO. In future, multimodal data-fusion could be used to predict disability outcomes in MS using a similar method to this work.
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![(A, B and C) show selected independent component analysis maps from resting-state networks of healthy controls that correspond to the (A) visual, (B) sensorimotor, and (C) default mode networks. (D) shows Jülich histological probability masks of (from left to right) the corpus callosum, optic radiation and corticospinal tracts.](gr1){#f0005}

![Diagram of multimodal data fusion, learning kernel weights and cross-validation.](gr2){#f0010}

![Boxplots show the median and 75th percentile for each variable extracted from (A) imaging or (B) clinical and cognitive assessments. Functional connectivity values are normalized (mean = 0, and SD = 1.5).](gr3){#f0015}

![Between predictor correlations for imaging, cognitive and clinical parameters in patients. Each row and column represent a predictor ([Table 1](#t0005){ref-type="table"}), and each rectangle represents the correlation coefficient between the corresponding variables on the *x* and *y* axes.](gr4){#f0020}

###### 

Measures that were used *a priori* to construct disease prediction models.

  Measures (predictors) and modalities                                         Description                                                                                                                                                                                                                        Previous evidence in MS                                                                                                                                                                                                         Previous evidence in NMO                                                                                                                                                   Method used for calculation
  ---------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Modality: gray matter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Cortical thickness                                                           Average of cortical thickness (in millimeters) from cortical regions in the Desikan-Killiany atlas[a](#ngtbl1.1){ref-type="table-fn"}.                                                                                             Gray matter is affected from the early stages by demyelination, axonal loss and neuronal degeneration[b](#ngtbl1.2){ref-type="table-fn"}.                                                                                       Gray matter is affected to a much lesser extent than in MS. Damage is secondary to astrocyte loss with less demyelination[c](#ngtbl1.3){ref-type="table-fn"}.              FreeSurfer software: thickness between white matter surface and pial surface.
  Deep gray matter (DGM)                                                       Average volumes of the thalamus, pallidum, caudate and globus pallidus (in cubic millimeters, both hemispheres).                                                                                                                   DGM nuclei (specifically the thalamus) are affected from the early stages. Damage may be secondary to axonal loss in other regions or primarily due to iron accumulation or demyelination[b](#ngtbl1.2){ref-type="table-fn"}.   Nuclei are also affected, possibly to a lesser extent than in MS[c](#ngtbl1.3){ref-type="table-fn"}.                                                                       Volumetric pipeline of subcortical segmentation in FreeSurfer.
  Modality: visible WM lesions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  T2/FLAIR lesion load                                                         Average of visible white matter lesion volume (cubic millimeters).                                                                                                                                                                 Visible lesions are the basis for a diagnosis of MS.                                                                                                                                                                            A pattern that is distinct from that of MS in the hypothalamus and brain stem, or sometimes a pattern similar to that observed in MS[d](#ngtbl1.4){ref-type="table-fn"}.   Jim software and SPM8:FLAIR lesion mask was calculated automatically (see text). Next, it was manually edited while comparing to T2 images.
  T1 lesion load                                                               Average of hypointense lesion volume (cubic millimeters).                                                                                                                                                                          T1 hypointense lesions could be better correlated with disability than T2 lesions[e](#ngtbl1.5){ref-type="table-fn"}.                                                                                                           Could be seen in destructive lesion[f](#ngtbl1.6){ref-type="table-fn"}.                                                                                                    Jim software: Hypointense lesions were manually marked and segmented by an expert neurologist
  Modality: DTI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Corpus callosum fractional anisotropy (normal-appearing white matter only)   Average of fractional anisotropy (FA) along the corticospinal tract, localized according to the Jülich histological atlas after exclusion of the visible lesion mask ([Fig. 1D](#f0005){ref-type="fig"}).                          A hallmark of MS; decreased white matter integrity is easily detectable in this area[g](#ngtbl1.7){ref-type="table-fn"}.                                                                                                        May be affected secondary to non-specific white matter lesions[g](#ngtbl1.7){ref-type="table-fn"}.                                                                         FSL software: binary mask of the corpus callosum was warped to the subjects\' native space; the visible white matter lesion mask was subtracted; and the mean average of FA was calculated.
  Corticospinal tract FA (normal-appearing white matter only)                  Average of FA along the corticospinal tract, localized according to the Jülich histological atlas after exclusion of the visible lesion mask ([Fig. 1D](#f0005){ref-type="fig"}).                                                  Presents a loss of integrity, which is associated with disability and clinical progression[h](#ngtbl1.8){ref-type="table-fn"}.                                                                                                  May present damage secondary to myelitis[i](#ngtbl1.9){ref-type="table-fn"}.                                                                                               FSL software: as described above, except with the corticospinal binary mask (bilateral).
  Optic radiation (normal-appearing white matter only)                         Average of FA along the bilateral optic radiation tract (reference atlas: Jülich histological atlas) after exclusion of the visible lesion mask ([Fig. 1D](#f0005){ref-type="fig"}).                                               Damaged in MS, secondary to trans-synaptic degeneration in the optic nerve and Wallerian degeneration due to local lesions[g](#ngtbl1.7){ref-type="table-fn"}.                                                                  DTI studies have revealed a loss of integrity in patients with NMO with distinct pathogenic processes compared with those of MS[h](#ngtbl1.8){ref-type="table-fn"}.        FSL software: as described above.
  Modality: fMRI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Sensorimotor network connectivity                                            Average of *Z*-scores in the network identified using group independent component analysis (ICA) in healthy controls ([Fig. 1B](#f0005){ref-type="fig"}).                                                                          Presents aberrant connectivity, which may be due to compensatory mechanisms or maladaptive plasticity[i](#ngtbl1.9){ref-type="table-fn"}.                                                                                       Only a handful of studies are available; may show aberrant connectivity[j](#ngtbl1.10){ref-type="table-fn"}.                                                               FSL software: independent components analysis (ICA) separates signals into underlying sources. Next, a dual-regression approach was used to extract functional connectivity values (*Z*-scores).
  Default mode network connectivity                                            Average of *Z*-scores in the network identified using group ICA in healthy controls ([Fig. 1C](#f0005){ref-type="fig"}).                                                                                                           Presents abnormal connectivity even in patients with clinically isolated syndrome and is known to be affected in other neurological or psychiatric disorders[i](#ngtbl1.9){ref-type="table-fn"}.                                A few studies have shown changes compared to healthy controls[j](#ngtbl1.10){ref-type="table-fn"}.                                                                         FSL software: the same method used for the sensorimotor network.
  Visual network                                                               Average of *Z*-scores in the visual network identified using group ICA.                                                                                                                                                            Visual network supports a "basic" function and failed to show any change in a previous study, it will be used here as a control network[i](#ngtbl1.9){ref-type="table-fn"}.                                                     --                                                                                                                                                                         Same method used for previous two networks.
  Upper cervical cord cross-sectional area                                     Average cross-sectional area from foramen magnum to C2.                                                                                                                                                                            Presents volume loss and is associated with disability[g](#ngtbl1.7){ref-type="table-fn"}.                                                                                                                                      Primarily affected during NMO.                                                                                                                                             Jim software: semiautomatic reconstruction of the spinal cord, followed by calculation of the average cross-sectional area (square millimeters).
  Modality: clinical scores                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  EDSS                                                                         EDSS score, assessed by the neurologist providing care.                                                                                                                                                                            Used as an outcome measure in MS clinical trials.                                                                                                                                                                               Originally developed for MS, but also applied to NMO.                                                                                                                      Neurological examination (ranging from 0--10).
  9-Hole peg test                                                              Part of the multiple sclerosis functional composite (MSFC). Tests upper motor disability and cerebellar functions.                                                                                                                 Associated with motor performance and cerebellar coordination.                                                                                                                                                                  Could be more impaired in NMO due to more devastating attacks.                                                                                                             Average of two trials with dominant and non-dominant hand in seconds.
  25-Foot walk test                                                            Part of the multiple sclerosis functional composite (MSFC).                                                                                                                                                                        Associated with motor performance and cerebellar coordination.                                                                                                                                                                  Could be impaired in NMO secondary to more severe attacks.                                                                                                                 Average of two trials in which patients walk a 25-foot distance as quickly as possible, measured in seconds.
  Low-contrast (2.5%) visual test                                              Sloan low-contrast letter acuity is a standardized measure suggested in addition to the MSFC.                                                                                                                                      This test has been extensively validated in MS trials and specifically relates to optic neuritis and general optic nerve damage in MS[k](#ngtbl1.11){ref-type="table-fn"}.                                                      Validated in NMO and associated with retinal axonal and neuronal loss[k](#ngtbl1.11){ref-type="table-fn"}.                                                                 Binocular testing: the total number of correct letters was counted and reported.
  Modality: cognitive scores                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Symbol Digit Modality Test (SDMT)                                            Evaluates information processing and working memory domains: 10 abstract symbols are paired with numbers ranging from 1 to 10. The subject is given 90 s to pair new symbols with the correct number.                              The most sensitive test able to detect cognitive impairment associated with MS in the Iranian population[l](#ngtbl1.12){ref-type="table-fn"}.                                                                                   Also affected in NMO due to cortical degeneration[m](#ngtbl1.13){ref-type="table-fn"}.                                                                                     Neuropsychological battery administered by a neuropsychologist: the total number of symbols correctly paired with the corresponding numbers in 90 s[l](#ngtbl1.12){ref-type="table-fn"}.
  California Verbal Learning Test (CVLT) version 2                             Evaluates short- and long-term verbal memory: a list of 10 words that are read to the subject 5 times; the subject then recalls the words, and the response is recorded. After 20 min, the subject is asked to recall the words.   The second most sensitive cognitive test in the Iranian population and used to detect MS-related cognitive weakness[l](#ngtbl1.12){ref-type="table-fn"}.                                                                        Verbal memory is also affected in NMO[m](#ngtbl1.13){ref-type="table-fn"}.                                                                                                 Neuropsychological battery administered by a neuropsychologist: the total number of correct words over the first 5 trials is defined as the "total learning score." The total number of recalled words after 20 min is defined as the "delayed recall score."
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###### 

Demographic characteristics.

  Measures                       Groups                        
  ------------------------------ -------------- -------------- --------------
  Mean age ± SD                  31.94 ± 9.07   33.58 ± 10.1   32.85 ± 8.49
  Mean disease duration ± SD     --             6.07 ± 3.29    8.04 ± 7.04
  Gender ratio (female:male)     31:4           26:4           22:3
  Mean years of education ± SD   13.4 ± 2.92    12.41 ± 3.58   12.96 ± 3.56

Healthy control.

Neuromyelitis optica.

Multiple sclerosis.

###### 

Importance ranking of significant modalities.

      Binary classification           Multi-class classification                                          
  --- ------------------------------- ------------------------------- ----------------------------------- -------------------------------
  1   Visible WM lesion load (0.20)   Visible WM lesion load (0.49)   Clinical scores (0.41)              Visible WM lesion load (0.38)
  2   DTI (0.18)                      DTI (0.16)                      Cognitive scores (0.18)             fMRI (0.31)
  3   fMRI (0.17)                     Clinical scores (0.13)          fMRI (0.16)                         Cognitive scores (0.16)
  4   Cognitive scores (0.16)         fMRI (0.10)                     DTI (0.13)                          DTI (0.14)
  5   Gray matter measures (0.15)     Cognitive scores (0.08)         Gray matter measures (0.10)         --
  6   Spinal cord area (0.06)         Gray matter measures (0.05)     Spinal cord area (0.002)            --
  7   Clinical scores (0.08)          Spinal cord area (0.004)        Visible WM lesion load (\<0.0001)   --

Multi-kernel learning combines different kernels and gives each of them a weight. Linear combination of each kernel and their weights will be used for the combined kernel. Here, relative weight is defined as the normalized weight that is given to each kernel, and is averaged for each modality over all 10 folds.
